At the 150th Annual General Meeting of Shareholders to be held on June 24, 2026, Julie Kim will be proposed as the new President and CEO, with the current CEO Christophe Weber scheduled to resign.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4502","jir_company_name":"Takeda Pharmaceutical Company Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-03-26","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4502-20260326-01.pdf","jir_short_summary":"At the 150th Annual General Meeting of Shareholders to be held on June 24, 2026, Julie Kim will be proposed as the new President and CEO, with the current CEO Christophe Weber scheduled to resign.","jir_summary":"### Overview of Director Candidates and Representative Director Changes\nTakeda Pharmaceutical Company Limited announced that at the 150th Annual General Meeting of Shareholders scheduled for June 24, 2026, Julie Kim will be proposed as the new President and CEO, and will assume office upon approval. The current President and CEO, Christophe Weber, will resign as of the same date. Additionally, three candidates for outside directors\u2014Bruce Broussard, Koichiro Kimura, and Paul Stoffels\u2014will be proposed, with six outside directors scheduled to resign. All other incumbent directors will be proposed for reappointment.\n\n### Background and Expectations for New Director Candidates\nThe new outside director candidate Bruce Broussard is interim CEO of HP Inc. and possesses extensive management experience in the healthcare sector. Koichiro Kimura is a former group leader of PwC Japan Group with strengths in addressing geopolitical risks. Paul Stoffels is a co-founder of Galapagos and former Chief Scientific Officer at Johnson & Johnson, having led innovative pharmaceutical development. The Board expects these new candidates to contribute to strengthening supervisory and advisory functions during this transformative period for the company.","jir_financial_highlights":"Date of Change for President and CEO: 2026-06-24 (New appointment of Julie Kim; resignation of current CEO Christophe Weber)\nNumber of New Outside Director Candidates: 3 (Bruce Broussard, Koichiro Kimura, Paul Stoffels)\nNumber of Outside Directors Resigning: 6 (Jean-Luc Butel and others)","jir_category":"","jir_hashtags":"#TakedaPharmaceuticalCompany, #ExecutivePersonnelChanges, #JapaneseStocks","jir_key_figures":"Scheduled Date for Change of President and CEO: 2026-06-24\nNumber of New Outside Director Candidates: 3\nNumber of Outside Directors Resigning: 6","jir_meta_title":"Takeda Pharmaceutical Announces Change of President and CEO and Director Appointments in June 2026","jir_meta_description":"Takeda Pharmaceutical Company will propose Julie Kim as new President and CEO at the Annual General Meeting on June 24, 2026, alongside a significant refresh of outside directors.","jir_og_title":"Takeda Pharmaceutical Announces CEO Change and Director Appointments (June 2026)","jir_og_description":"Takeda proposes Julie Kim as the next CEO, appoints three new outside directors, and plans for six resignations, strengthening corporate governance during a transformational phase.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6852,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-36873","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n